Correction to: mTOR co-targeting strategies for head and neck cancer therapy

Eitemau Tebyg

• mTOR co-targeting strategies for head and neck cancer therapy
  gan: Wang, Zhiyong, et al.
  Cyhoeddwyd: (2017)
• mTOR Co-Targeting in Cetuximab Resistance in Head and Neck Cancers Harboring PIK3CA and RAS Mutations
  gan: Wang, Zhiyong, et al.
  Cyhoeddwyd: (2014)
• mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
  gan: Gao, Wei, et al.
  Cyhoeddwyd: (2012)
• Exploiting the head and neck cancer oncogenome: Widespread PI3K-mTOR pathway alterations and novel molecular targets
  gan: Iglesias-Bartolome, Ramiro, et al.
  Cyhoeddwyd: (2013)
• mTOR Signalling in Head and Neck Cancer: Heads Up
  gan: Tan, Fiona H., et al.
  Cyhoeddwyd: (2019)